Related Experiment Video
Updated: Jul 15, 2025
Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies
Published on: June 20, 2015
A niche-mimicking polymer hydrogel-based approach to identify molecular targets for tackling human pancreatic cancer
Yoshitaka Murota1, Mariko Nagane1, Mei Wu2
1Department of Stem Cell Regulation, Medical Research Institute, Tokyo Medical and Dental University (TMDU), 1-5-45, Yushima, Bunkyo-Ku, Tokyo, 113-8510, Japan.
Background:
Pancreatic adenocarcinoma (PAAD) is one of the most fatal human cancers, but effective therapies remain to be established. Cancer stem cells (CSCs) are highly resistant to anti-cancer drugs and a deeper understanding of their microenvironmental niche has been considered important to provide understanding and solutions to cancer eradication. However, as the CSC niche is composed of a wide variety of biological and physicochemical factors, the development of multidisciplinary tools that recapitulate their complex features is indispensable. Synthetic polymers have been studied as attractive biomaterials due to their tunable biofunctionalities, while hydrogelation technique further renders upon them a diversity of physical properties, making them an attractive tool for analysis of the CSC niche.
Methods:
To develop innovative materials that recapitulate the CSC niche in pancreatic cancers, we performed polymer microarray analysis to identify niche-mimicking scaffolds that preferentially supported the growth of CSCs. The niche-mimicking activity of the identified polymers was further optimized by polyethylene glycol (PEG)-based hydrogelation. To reveal the biological mechanisms behind the activity of the optimized hydrogels towards CSCs, proteins binding onto the hydrogel were analyzed by liquid chromatography with tandem mass spectrometry (LC-MS/MS), and the potential therapeutic targets were validated by looking at gene expression and patients' outcome in the TCGA database.
Results:
PA531, a heteropolymer composed of 2-methoxyethyl methacrylate (MEMA) and 2-(diethylamino)ethyl methacrylate (DEAEMA) (5.5:4.5) that specifically supports the growth and maintenance of CSCs was identified by polymer microarray screening using the human PAAD cell line KLM1. The polymer PA531 was converted into five hydrogels (PA531-HG1 to HG5) and developed to give an optimized scaffold with the highest CSC niche-mimicking activities. From this polymer that recapitulated CSC binding and control, the proteins fetuin-B and angiotensinogen were identified as candidate target molecules with clinical significance due to the correlation between gene expression levels and prognosis in PAAD patients and the proteins associated with the niche-mimicking polymer.
Conclusion:
This study screened for biofunctional polymers suitable for recapitulation of the pancreatic CSC niche and one hydrogel with high niche-mimicking abilities was successfully fabricated. Two soluble factors with clinical significance were identified as potential candidates for biomarkers and therapeutic targets in pancreatic cancers. Such a biomaterial-based approach could be a new platform in drug discovery and therapy development against CSCs, via targeting of their niche.
Insights
Researchers developed a novel hydrogel to mimic the pancreatic cancer stem cell niche, identifying fetuin-B and angiotensinogen as potential therapeutic targets for pancreatic adenocarcinoma (PAAD). This approach aids in drug discovery for this fatal cancer.
Area of Science:
- Biomaterials Science
- Cancer Biology
- Drug Discovery
Background:
- Pancreatic adenocarcinoma (PAAD) is a highly fatal cancer with limited effective therapies.
- Cancer stem cells (CSCs) contribute to treatment resistance, necessitating a deeper understanding of their microenvironment.
- Synthetic polymers and hydrogels offer tunable properties for recapitulating complex CSC niches.
Purpose of the Study:
- To develop innovative biomaterials that mimic the pancreatic CSC niche.
- To identify novel therapeutic targets and biomarkers for PAAD.
- To establish a platform for drug discovery against CSCs.
Main Methods:
- Utilized polymer microarray analysis to screen for CSC niche-mimicking scaffolds.
- Optimized promising polymers into polyethylene glycol (PEG)-based hydrogels.
- Employed liquid chromatography-tandem mass spectrometry (LC-MS/MS) to identify binding proteins and TCGA database analysis for target validation.
Main Results:
- Identified PA531, a heteropolymer supporting CSC growth and maintenance.
- Developed optimized hydrogels (PA531-HG1 to HG5) with high CSC niche-mimicking activity.
- Discovered fetuin-B and angiotensinogen as candidate therapeutic targets, correlating with PAAD patient prognosis.
Conclusions:
- Successfully fabricated a hydrogel capable of recapitulating the pancreatic CSC niche.
- Identified two clinically significant soluble factors (fetuin-B, angiotensinogen) as potential biomarkers and therapeutic targets.
- A biomaterial-based approach offers a novel platform for targeting CSCs and developing new therapies for pancreatic cancer.
